Published in Eur J Nucl Med on January 01, 1989
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J Cell Biol (1989) 4.81
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. Am J Transplant (2011) 1.90
Human cell surface proteins selectively assembled into vesicular stomatitis virus virions. Virology (1983) 1.74
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant (2012) 1.42
Live donor renal transplantation in Australia 1964-1999: an evolving practice. Intern Med J (2002) 1.39
Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol (1993) 1.34
Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation. J Immunol (1993) 1.25
Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J Gen Virol (2008) 1.21
The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents (2010) 1.15
Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab (1989) 1.14
An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J Virol (1998) 1.09
The molecular weight determination of proteins and glycoproteins of RNA enveloped viruses by polyacrylamide gel electrophoresis in SDS. Biochem Biophys Res Commun (1973) 1.03
Renal failure from "glue sniffing". Med J Aust (1981) 1.03
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. Am J Transplant (2009) 1.02
On the relationship between respiratory activity and lipid composition of the yeast cell. Biochim Biophys Acta (1967) 1.00
Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci (1988) 0.97
Preparation of monoclonal antibodies for the diagnosis of influenza A infection using different immunization protocols. J Immunol Methods (1995) 0.96
Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules. Arch Virol (1993) 0.93
Vibrio alginolyticus peritonitis associated with ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 0.92
The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin. J Gen Virol (2000) 0.91
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. II. Reactivity with rabbit sera against intact virus and purified undissociated haemagglutinin. Acta Virol (1978) 0.90
Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients. Am J Transplant (2013) 0.89
FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study. Am J Transplant (2006) 0.88
Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2. Arch Virol (1988) 0.88
Cefsulodin penetration into rat brain: extracellular versus total concentration. Chemotherapy (1986) 0.88
Antibody against Hong Kong influenza viruses in pigs. Acta Virol (1971) 0.86
Phase II study of single-agent pegylated liposomal doxorubicin HCl (PLD) in metastatic breast cancer after first-line treatment failure. Onkologie (2004) 0.86
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides. Acta Virol (1979) 0.86
Permeability of nitroimidazoles in rat cortex. Chemotherapy (1986) 0.84
PB1-F2 expedition from the whole protein through the domain to aa residue function. Acta Virol (2013) 0.83
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. Acta Virol (1979) 0.83
Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome. Am J Transplant (2007) 0.83
Interaction of Staphylococcus aureus with human neutrophils and the down-regulation of TNF receptors. J Immunol (1994) 0.83
The transmission of donor-derived malignant melanoma to a renal allograft recipient. Clin Transplant (2006) 0.83
Determination of antibiotic lipophilicity with a micromethod: application to brain permeability in man and rats. Chemotherapy (1988) 0.82
Assessment by dipyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery. Surgery (1988) 0.81
PB1-F2 gene in influenza a viruses of different hemagglutinin subtype. Acta Virol (2006) 0.81
Role of pulmonary blood flow in postpneumonectomy lung growth. J Appl Physiol (1985) (1992) 0.80
Measurement and clinical and pharmacokinetic implications of diffusion coefficients of antibiotics in tissues. Antimicrob Agents Chemother (1989) 0.80
Processing and presentation of antigens to class I restricted T lymphocytes. Year Immunol (1990) 0.79
Characterization of influenza A-1983 epidemic strains by polyclonal and monoclonal antibodies and detection of two co-circulating antigenic variants. Acta Virol (1986) 0.79
Modulation of HLA-G expression. Neoplasma (2007) 0.79
Thrombotic microangiopathy related to anticardiolipin antibody in a renal allograft. Nephrol Dial Transplant (1999) 0.79
Influenza a virus PB1-F2 protein. Acta Virol (2007) 0.79
Immunity in latent Herpes simplex virus infection. Acta Virol (2005) 0.79
Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma (2000) 0.79
N-terminal region of the PB1-F2 protein is responsible for increased expression of influenza A viral protein PB1. Acta Virol (2011) 0.79
Dissociation of beta 2-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Mol Immunol (1993) 0.78
Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines. Leuk Res (2008) 0.78
The multifaceted effect of PB1-F2 specific antibodies on influenza A virus infection. Virology (2013) 0.78
Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients. Neoplasma (2009) 0.78
Stable inheritance of an HLA-"blank" phenotype associated with a structural mutation in the HLA-A*0301 gene. Tissue Antigens (1996) 0.77
Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection. Acta Virol (1997) 0.77
Antigen processing: where tumor-specific T-cell responses begin. J Immunother Emphasis Tumor Immunol (1993) 0.77
Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2. Acta Virol (1989) 0.77
Antigenic relatedness of alphaherpesviruses isolated from free-living rodents. Acta Virol (1982) 0.77
Continuous sampling for determination of pharmacokinetics in rat cerebrospinal fluid. Antimicrob Agents Chemother (1986) 0.76
Impact of blood processing on estimation of soluble HLA-G. Neoplasma (2011) 0.76
Rescue of presumptive viral information from human cells by a helper oncovirus. J Gen Virol (1986) 0.76
HLA class I variation in Australian aborigines: characterization of allele B*1521. Tissue Antigens (1995) 0.76
HLA DPB1 genotyping in Australian aborigines by amplified fragment length polymorphism analysis. Hum Immunol (1993) 0.76
De novo immunosuppression with mammalian target of rapamycin inhibitors and posttransplantation malignancy in focus. Transplant Proc (2009) 0.75
Histological standardisation of renal transplant rejection. Aust N Z J Med (1995) 0.75
Use of Staphylococcus aureus for rapid radioimmunoassay of influenza A virus haemagglutinin. Acta Virol (1979) 0.75
Improved detection by immunodiffusion of type-specific influenza antibody in avian sera. Acta Virol (1978) 0.75
The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells. Ann N Y Acad Sci (1980) 0.75
A simple and rapid characterization of influenza virus isolates by monoclonal antibodies in radioimmunoassay. Acta Virol (1986) 0.75
Purification of tick-borne encephalitis virus by affinity chromatography using monoclonal antibody. Acta Virol (1984) 0.75
[Biology of the influenza viruses]. Bratisl Lek Listy (1983) 0.75
Analysis of influenza A virus neuraminidase using lectin test and monoclonal antibodies. Acta Virol (1986) 0.75
Production of monoclonal antibodies with haemagglutination-inhibition activity to the Skalica strain from the tick-borne encephalitis complex. Acta Virol (1983) 0.75
Characterization of a monoclonal antibody with CD44 like reactivity. Dis Markers (1992) 0.75
Radioimmunoassay of influenza A virus haemagglutinin. II. Antigenic cross-reactions of influenza A (H3 subtype) viruses as determined by radioimmunoassay and haemagglutination inhibition tests. Acta Virol (1980) 0.75
Effect of a proteolytic enzyme inhbitor on influenza virus replication. Acta Virol (1977) 0.75
Indication and study of antigenic properties of influenza virus internal proteins by means of monoclonal antibodies. Acta Virol (1985) 0.75
Reduced expression of HLA-DP antigens on PWM stimulated T lymphocytes in patients suffering from psoriasis vulgaris. Immunobiology (1991) 0.75
Acute renal failure due to bilateral ureteral hematomas complicating anticoagulant therapy. Nephron (1993) 0.75
Vesicular stomatitis virus phenotypically mixed with retroviruses: an efficient detection method. Acta Virol (1983) 0.75
Use of monoclonal antibodies against avian retroviral protein p19 for competitive radioimmunoassay and immunodiffusion. Neoplasma (1983) 0.75
Use of cross-linking in studying the structure of RNA tumour viruses. Acta Virol (1976) 0.75
Production and characterization of monoclonal antibodies against avian myeloblastosis virus. Neoplasma (1983) 0.75
Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2. Acta Virol (1991) 0.75
Electrophoretic separation and characterization of subunits released from influenza virus by detergents. Acta Virol (1976) 0.75
[Treatment of painful neuromas of the hand by intra-osseous implantation]. Ann Chir Main (1987) 0.75
[Expression of HLA antigens using the radioimmunoanalysis method]. Bratisl Lek Listy (1989) 0.75
Localization of major group-specific polypeptides in the avian RNA tumor viruses. Biochem Biophys Res Commun (1974) 0.75
Evaluation of the effectiveness of receptor destroying enzyme preparations. Acta Virol (1977) 0.75
[The effect of certain substances on changes in the expression of class II HLA antigens]. Cas Lek Cesk (1989) 0.75
Use of Brefeldin A to localize block in intracellular transport of vesicular stomatitis virus G protein on interferon-treated cells. Arch Virol (1992) 0.75
Monoclonal antibody against an antigen selectively assembled into vesicular stomatitis virus virions from HeLa cells. Int J Cancer (1984) 0.75
Use of virus recombinants in the analysis of influenza virus antigens. Acta Virol (1971) 0.75
Radioimmunoassay of influenza A virus haemagglutinin. I. Preparation and properties of radioactive 125I-labelled bromelain-released haemagglutinin. Acta Virol (1978) 0.75
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. I. Gel filtration in 6 M guanidine hydrochloride. Acta Virol (1978) 0.75
Interaction of oncornaviral proteins separated by SDS-PAGE with antibodies in immunodiffusion. Neoplasma (1977) 0.75
A competitive-inhibition radioimmunoassay for influenza virus envelope antigens. Acta Virol (1976) 0.75
[Preparation and use of monoclonal antibodies]. Bratisl Lek Listy (1983) 0.75
Growth inhibitory effect of mouse interferon in transformed cells. Acta Microbiol Acad Sci Hung (1981) 0.75
Marked difference in electrophoretic migration rates between two influenza A viruses. Acta Virol (1978) 0.75